Journal of Medicinal Chemistry
Article
permeability in drug discovery and development settings. Adv. Drug
Delivery Rev. 2001, 46 (1−3), 3−26.
(12) Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.
Experimental and computational approaches to estimate solubility and
permeability in drug discovery and development settings. Adv. Drug
Delivery Rev. 1997, 23 (1−3), 3−25.
(13) Giordanetto, F.; Kihlberg, J. Macrocyclic drugs and clinical
candidates: What can medicinal chemists learn from their properties? J.
Med. Chem. 2014, 57, 278−295.
(14) Bockus, A. T.; McEwen, C. M.; Lokey, R. S. Form and function
in cyclic peptide natural products: a pharmacokinetic perspective. Curr.
Top. Med. Chem. 2013, 13 (7), 821−836.
(15) White, T. R.; Renzelman, C. M.; Rand, A. C.; Rezai, T.;
McEwen, C. M.; Gelev, V. M.; Turner, R. A.; Linington, R. G.; Leung,
S. S.; Kalgutkar, A. S.; Bauman, J. N.; Zhang, Y.; Liras, S.; Price, D. A.;
Mathiowetz, A. M.; Jacobson, M. P.; Lokey, R. S. On-resin N-
methylation of cyclic peptides for discovery of orally bioavailable
scaffolds. Nat. Chem. Biol. 2011, 7 (11), 810−817.
(16) Ashwood, V. A.; Field, M. J.; Horwell, D. C.; Julien-Larose, C.;
Lewthwaite, R. A.; McCleary, S.; Pritchard, M. C.; Raphy, J.; Singh, L.
Utilization of an intramolecular hydrogen bond to increase the CNS
penetration of an NK(1) receptor antagonist. J. Med. Chem. 2001, 44
(14), 2276−2285.
(17) Over, B.; McCarren, P.; Artursson, P.; Foley, M.; Giordanetto,
F.; Gronberg, G.; Hilgendorf, C.; Lee, M. D. t.; Matsson, P.;
Muncipinto, G.; Pellisson, M.; Perry, M. W.; Svensson, R.; Duvall, J.
R.; Kihlberg, J. Impact of stereospecific intramolecular hydrogen
bonding on cell permeability and physicochemical properties. J. Med.
Chem. 2014, 57 (6), 2746−2754.
(18) Ettorre, A.; D’Andrea, P.; Mauro, S.; Porcelloni, M.; Rossi, C.;
Altamura, M.; Catalioto, R. M.; Giuliani, S.; Maggi, C. A.; Fattori, D.
hNK2 receptor antagonists. The use of intramolecular hydrogen
bonding to increase solubility and membrane permeability. Bioorg.
Med. Chem. Lett. 2011, 21 (6), 1807−1809.
(19) Wu, C.; Decker, E. R.; Blok, N.; Li, J.; Bourgoyne, A. R.; Bui, H.;
Keller, K. M.; Knowles, V.; Li, W.; Stavros, F. D.; Holland, G. W.;
Brock, T. A.; Dixon, R. A. Acyl substitution at the ortho position of
anilides enhances oral bioavailability of thiophene sulfonamides:
TBC3214, an ETA selective endothelin antagonist. J. Med. Chem.
2001, 44 (8), 1211−1216.
(20) Sasaki, S.; Cho, N.; Nara, Y.; Harada, M.; Endo, S.; Suzuki, N.;
Furuya, S.; Fujino, M. Discovery of a thieno[2,3-d]pyrimidine-2,4-
dione bearing a p-methoxyureidophenyl moiety at the 6-position: a
highly potent and orally bioavailable non-peptide antagonist for the
human luteinizing hormone-releasing hormone receptor. J. Med. Chem.
2003, 46 (1), 113−124.
(21) Rafi, S. B.; Hearn, B. R.; Vedantham, P.; Jacobson, M. P.;
Renslo, A. R. Predicting and improving the membrane permeability of
peptidic small molecules. J. Med. Chem. 2012, 55 (7), 3163−3169.
(22) Rezai, T.; Bock, J. E.; Zhou, M. V.; Kalyanaraman, C.; Lokey, R.
S.; Jacobson, M. P. Conformational flexibility, internal hydrogen
bonding, and passive membrane permeability: successful in silico
prediction of the relative permeabilities of cyclic peptides. J. Am. Chem.
Soc. 2006, 128 (43), 14073−14080.
(23) Rezai, T.; Yu, B.; Millhauser, G. L.; Jacobson, M. P.; Lokey, R. S.
Testing the conformational hypothesis of passive membrane
permeability using synthetic cyclic peptide diastereomers. J. Am.
Chem. Soc. 2006, 128 (8), 2510−2511.
(24) Yudin, A. K. Macrocycles: lessons from the distant past, recent
developments, and future directions. Chem. Sci. 2015, 6 (1), 30−49.
(25) Beck, J. G.; Chatterjee, J.; Laufer, B.; Kiran, M. U.; Frank, A. O.;
Neubauer, S.; Ovadia, O.; Greenberg, S.; Gilon, C.; Hoffman, A.;
Kessler, H. Intestinal permeability of cyclic peptides: common key
backbone motifs identified. J. Am. Chem. Soc. 2012, 134 (29), 12125−
12133.
(26) Thansandote, P.; Harris, R. M.; Dexter, H. L.; Simpson, G. L.;
Pal, S.; Upton, R. J.; Valko, K. Improving the passive permeability of
macrocyclic peptides: balancing permeability with other physicochem-
ical properties. Bioorg. Med. Chem. 2015, 23 (2), 322−327.
(27) Klages, J.; Neubauer, C.; Coles, M.; Kessler, H.; Luy, B.
Structure refinement of cyclosporin A in chloroform by using RDCs
measured in a stretched PDMS-gel. ChemBioChem 2005, 6 (9), 1672−
1678.
(28) Kessler, H.; Gehrke, M.; Lautz, J.; Kock, M.; Seebach, D.;
Thaler, A. Complexation and medium effects on the conformation of
cyclosporin A studied by NMR spectroscopy and molecular dynamics
calculations. Biochem. Pharmacol. 1990, 40 (1), 169−173.
(29) Xu, Y.; Kersten, R. D.; Nam, S. J.; Lu, L.; Al-Suwailem, A. M.;
Zheng, H.; Fenical, W.; Dorrestein, P. C.; Moore, B. S.; Qian, P. Y.
Bacterial biosynthesis and maturation of the didemnin anti-cancer
agents. J. Am. Chem. Soc. 2012, 134 (20), 8625−8632.
(30) Masuoka, Y.; Nagai, A.; Shin-ya, K.; Furihata, K.; Nagai, K.;
Suzuki, K.; Hayakawa, Y.; Seto, H. Spiruchostatins A and B, novel gene
expression-enhancing substances produced by Pseudomonas sp.
Tetrahedron. Lett. 2001, 42 (1), 41−44.
(31) Yurek-George, A.; Habens, F.; Brimmell, M.; Packham, G.;
Ganesan, A. Total synthesis of spiruchostatin A, a potent histone
deacetylase inhibitor. J. Am. Chem. Soc. 2004, 126 (4), 1030−1031.
(32) Linington, R. G.; Clark, B. R.; Trimble, E. E.; Almanza, A.;
Urena, L. D.; Kyle, D. E.; Gerwick, W. H. Antimalarial peptides from
marine cyanobacteria: isolation and structural elucidation of
gallinamide A. J. Nat. Prod. 2009, 72 (1), 14−17.
(33) Coleman, J. E.; Desilva, E. D.; Kong, F. M.; Andersen, R. J.;
Allen, T. M. Cytotoxic peptides from the marine sponge Cymbastela
sp. Tetrahedron 1995, 51 (39), 10653−10662.
(34) Walsh, C. T.; O’Brien, R. V.; Khosla, C. Nonproteinogenic
amino acid building blocks for nonribosomal peptide and hybrid
polyketide scaffolds. Angew. Chem., Int. Ed. 2013, 52 (28), 7098−7124.
(35) Tan, L. T.; Okino, T.; Gerwick, W. H. Bouillonamide: a mixed
polyketide-peptide cytotoxin from the marine cyanobacterium Moorea
bouillonii. Mar. Drugs 2013, 11 (8), 3015−3024.
(36) Hill, T. A.; Shepherd, N. E.; Diness, F.; Fairlie, D. P.
Constraining cyclic peptides to mimic protein structure motifs. Angew.
Chem., Int. Ed. 2014, 53 (48), 13020−13041.
(37) Hagihara, M.; Anthony, N.; Stout, T.; Clardy, J.; Schreiber, S.
Vinylogous polypeptidesan alternative peptide backbone. J. Am.
Chem. Soc. 1992, 114 (16), 6568−6570.
(38) Guimaraes, C. R.; Mathiowetz, A. M.; Shalaeva, M.; Goetz, G.;
Liras, S. Use of 3D properties to characterize beyond rule-of-5
property space for passive permeation. J. Chem. Inf. Model. 2012, 52
(4), 882−890.
(39) Ovadia, O.; Greenberg, S.; Chatterjee, J.; Laufer, B.; Opperer, F.;
Kessler, H.; Gilon, C.; Hoffman, A. The effect of multiple N-
methylation on intestinal permeability of cyclic hexapeptides. Mol.
Pharmaceutics 2011, 8 (2), 479−487.
(40) Marzinzik, A. L.; Vorherr, T. E. Towards intracellular delivery of
peptides. Chimia 2013, 67 (12−13), 899−904.
(41) Bock, J. E.; Gavenonis, J.; Kritzer, J. A. Getting in shape:
controlling peptide bioactivity and bioavailability using conformational
constraints. ACS Chem. Biol. 2013, 8 (3), 488−499.
(42) Wahyudi, H.; Tantisantisom, W.; Liu, X.; Ramsey, D. M.; Singh,
E. K.; McAlpine, S. R. Synthesis, structure-activity analysis, and
biological evaluation of sanguinamide B analogues. J. Org. Chem. 2012,
77 (23), 10596−10616.
(43) Alex, A.; Millan, D. S.; Perez, M.; Wakenhut, F.; Whitlock, G. A.
Intramolecular hydrogen bonding to improve membrane permeability
and absorption in beyond rule of five chemical space. MedChemComm
2011, 2 (7), 669−674.
(44) Nielsen, D. S.; Hoang, H. N.; Lohman, R. J.; Diness, F.; Fairlie,
D. P. Total synthesis, structure, and oral absorption of a thiazole cyclic
peptide, sanguinamide A. Org. Lett. 2012, 14 (22), 5720−5723.
(45) Biron, E.; Chatterjee, J.; Ovadia, O.; Langenegger, D.; Brueggen,
J.; Hoyer, D.; Schmid, H. A.; Jelinek, R.; Gilon, C.; Hoffman, A.;
Kessler, H. Improving oral bioavailability of peptides by multiple N-
methylation: somatostatin analogues. Angew. Chem., Int. Ed. 2008, 47
(14), 2595−2599.
H
J. Med. Chem. XXXX, XXX, XXX−XXX